Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.
Mã chứng khoánHBIO
Tên công tyHarvard Bioscience Inc
Ngày IPOOct 21, 2013
Giám đốc điều hànhMr. John D. Duke
Số lượng nhân viên330
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhOct 21
Địa chỉ84 October Hill Rd
Thành phốHOLLISTON
Sàn giao dịch chứng khoánNASDAQ Global Market Consolidated
Quốc giaUnited States of America
Mã bưu điện01746-1371
Điện thoại15088938999
Trang webhttps://www.harvardbioscience.com/
Mã chứng khoánHBIO
Ngày IPOOct 21, 2013
Giám đốc điều hànhMr. John D. Duke
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu